Literature DB >> 19096598

A case of myelopathy after intrathecal injection of fluorescein.

Kwang-Yeol Park1, Young Baeg Kim.   

Abstract

We present a case with seizure, confusion, hypesthesia and paraplegia after intrathecal injection of fluorescein. A 41-year-old man was admitted to our institution for the management of the CSF leakage. Intrathecal injection of fluorescein was performed and he complained of severe pain and numbness in the lower extremities at the end of the injection. Four hours later, he exhibited confusion, paraparesis and two episodes of generalized seizures. Two days later, he showed paraplegia and all sensory modalities below the T12 level were absent. Spine magnetic resonance imaging revealed myelopathic change in the lower thoracic spinal cord. There was no improvement of weakness and sensory deficits in lower extremity even 14 days after fluorescein injection. We speculated that thoracic myelopathy was associated with the intrathecal injection of fluorescein. In spite of its rarity, the complication after intrathecal injection of fluorescein could be serious. Thus, obtaining an informed consent with discussion with patient before the procedure is mandatory.

Entities:  

Keywords:  Fluorescein; Intrathecal; Myelopathy

Year:  2007        PMID: 19096598      PMCID: PMC2588173          DOI: 10.3340/jkns.2007.42.6.492

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


  13 in total

1.  Use of fluorescein for the diagnosis and localization of cerebrospinal fluid fistulas.

Authors:  F R KIRCHNER
Journal:  Surg Forum       Date:  1961

Review 2.  Delayed absence seizure: a complication of intrathecal fluorescein injection. A case report and literature review.

Authors:  Shahram Anari; Murray Waldron; Sean Carrie
Journal:  Auris Nasus Larynx       Date:  2006-10-19       Impact factor: 1.863

3.  Intrathecal fluorescein in endoscopic skull base surgery.

Authors:  Abtin Tabaee; Dimitris G Placantonakis; Theodore H Schwartz; Vijay K Anand
Journal:  Otolaryngol Head Neck Surg       Date:  2007-08       Impact factor: 3.497

4.  Status epilepticus as a complication of intrathecal fluorescein. Case report.

Authors:  J D Wallace; M I Weintraub; R H Mattson; R Rosnagle
Journal:  J Neurosurg       Date:  1972-05       Impact factor: 5.115

5.  Spectrum of complications in the use of intrathecal fluorescein.

Authors:  J I Moseley; C A Carton; W E Stern
Journal:  J Neurosurg       Date:  1978-05       Impact factor: 5.115

6.  A new technique for the use of intrathecal fluorescein in the repair of cerebrospinal fluid rhinorrhea using a hypodense diluent.

Authors:  R Guimarães; H Becker
Journal:  Rev Laryngol Otol Rhinol (Bord)       Date:  2001

7.  Complication following intrathecal injection of fluorescein.

Authors:  M S Mahaley; G L Odom
Journal:  J Neurosurg       Date:  1966-09       Impact factor: 5.115

8.  Transnasal endoscopic repair of cerebrospinal fluid rhinorrhea: a meta-analysis.

Authors:  H M Hegazy; R L Carrau; C H Snyderman; A Kassam; J Zweig
Journal:  Laryngoscope       Date:  2000-07       Impact factor: 3.325

9.  Safety of low-dose intrathecal fluorescein in endoscopic cranial base surgery.

Authors:  Dimitris G Placantonakis; Abtin Tabaee; Vijay K Anand; David Hiltzik; Theodore H Schwartz
Journal:  Neurosurgery       Date:  2007-09       Impact factor: 4.654

10.  Use of sodium fluorescein solution for detection of cerebrospinal fluid fistulas: an analysis of 420 administrations and reported complications in Europe and the United States.

Authors:  Rainer Keerl; Rainer K Weber; Wolfgang Draf; A Wienke; Steven D Schaefer
Journal:  Laryngoscope       Date:  2004-02       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.